we report that hematopoietic progenitor cells expressing the cd34 antigen ( cd34+ cells ) transiently circulate in the peripheral blood ( pb ) of cancer patients treated with 7 g/m2 cyclophosphamide ( hd-ctx ) with or without recombinant human granulocyte macrophage-colony stimulating factor ( rhugm-csf ) .
C0018956
hematopoietic progenitor cells
C0054953
cd34 antigen